Liao is also an expert on diseases causing eye movement abnormality and double vision. Liao’s research areas also include: (1) development of state-of-the-art in vivo imaging techniques in the eye as novel biomarkers of disease (2) investigations of the key cellular and molecular changes in optic neuropathies leading to vision loss, including the use of patient specimen and stem cell research and (3) testing of novel treatment for optic neuropathies, including neuroprotection and regenerative therapy.ĭr. Her research lab aims to identify the first genes for autosomal dominant optic disc drusen.
Liao is studying OPTIC NERVE STROKE (also called anterior ischemic optic neuropathy), which is the most common acute optic neuropathy in those older than 50 years of age, and OPTIC DISC DRUSEN, which is associated with deposition of calcified deposits in the optic nerve and the most common cause of young-onset optic nerve stroke. Disruption of this important information highway leads to visual dysfunction despite good function in the retina and the brain. Liao’s research is focused on the pathogenesis and novel treatment of optic neuropathies, which are diseases affecting the 1.2 million axons connecting the eye (captures visual information) and the brain (interprets visual information). She also serves as Co-Director of the T32-funded Stanford Postdoctoral Vision Training Program since 2009.ĭr.
She has served as Director of the Neuro-Ophthalmology since 2008 and Founding Director of the Stanford Center for Optic Disc Drusen since 2019. in Neuroscience (Medical Scientist Training Program) and Fellowship in Neuro-Ophthalmology from University of California San Francisco. Liao received her undergraduate degree with high honors from Harvard University in Biochemical Sciences and her M.D., Ph.D. Liao is a clinician-scientist who is dedicated to making basic discoveries and improving clinical care and treatment of patients with eye-brain diseases.
0 kommentar(er)
